NCT07071077Recruiting
Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans
Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans With Hypertension
Source: ClinicalTrials.gov · Last updated 17 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 24 Feb 2025
- Start date
- 29 Jan 2025
- Primary completion date
- 31 May 2026
- Lead sponsor
- University of Delaware
- Diseases
- High blood pressure
- NCT number
- NCT07071077
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 29 Jan 2025 to the primary completion date, 31 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Cognitive limitations that limit the ability to provide informed consent
- Pregnancy
- Unable to speak or read English
- Planning to relocate during the study period
Who the study is looking for
- African American/Black
- Diagnosed with Hypertension
- Prescribed medication for hypertension
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Delaware Coordinator of this site? Confirm its status | Newark | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.